GlobalIPNews

Sign Up
|
Login
|

03:07:29 Thu 13 Aug 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Tianjin University

(57)

Shanghai Jiao Tong Univer

(49)

Chongqing Shenghuaxi Phar

(17)

Nantong University

(12)

Tianjin University of Tec

(8)

(7)

(6)

Beijing Sun Novo Pharmace

(6)

Hisamitsu Pharmaceutical

(6)

Gilead Sciences

(5)

Hanmi Pharmaceutical

(5)

Renji Hospital Shanghai J

(5)

Tianjin University of Sci

(5)

Dalian Institute of Chemi

(4)

Hoffmann La Roche

(4)

Hoffmann La Roche Inc [us

(4)

Jinling Pharmaceutical Co

(4)

Ruijin Hospital Shanghai

(4)

(4)

Shanghai Infectious Disea

(4)

(4)

West China Hospital, Sich

(4)

Alpha Pharmaceutical Co L

(3)

Bios-Therapy Physiologica

(3)

Changzhou Redsun Pharmace

(3)

China Pharmaceutical Univ

(3)

Chongqing Wanzhou Jinrui

(3)

Eli Lilly and Company

(3)

(3)

Janssen Biotech

(3)

Mirati Therapeutics

(3)

Nanjing University of Chi

(3)

Qilu Pharmaceutical

(3)

Revolution Medicines

(3)

Ruike Group Xiamen Co Ltd

(3)

Shaanxi Didu Pharmaceutic

(3)

Shandong New Time Pharmac

(3)

Shangdong Luoxin Pharmace

(3)

Shenyang Pharmaceutical U

(3)

Skyhawk Therapeutics

(3)

Southern Medical Universi

(3)

Sumitomo Pharma

(3)

Tandem Diabetes Care

(3)

Tianjin University Zhejia

(3)

Tianjin University of Tec

(3)

Ab2 Therapeutics S L

(2)

Anhui Menovo Pharmaceutic

(2)

Anhui University of Chine

(2)

(2)

Azurity Pharmaceuticals

(2)

Beijing Subenyuanhe Biote

(2)

Beijing Zhongke Gene Tech

(2)

Beone Medicines I Gmbh

(2)

Binzhou Medical College

(2)

(2)

Boehringer Ingelheim Vetm

(2)

Changchun Feiruibailin Ph

(2)

Changzhou Pharmaceutical

(2)

Changzhou Yabang Qh Pharm

(2)

Chengdu Brilliant Pharmac

(2)

China Japan Friendship Ho

(2)

China Three Gorges; Shang

(2)

(2)

(2)

First Affiliated Hospital

(2)

Fortvita Biologics Inc

(2)

Fundacion Publica Galega

(2)

(2)

Graviton Pharmaceuticals

(2)

Guangdong HEC Pharmaceuti

(2)

Guangdong Nanguo Pharmace

(2)

Guizhou Sanli Pharmaceuti

(2)

Hainan Medical Univ Haina

(2)

Hangzhou Zhongda Pharmace

(2)

Harbin Medical University

(2)

Harbin Veterinary Researc

(2)

Henan Guochuang Synthetic

(2)

Henan Univ Of Medicine

(2)

Hubei Shenghui Hongyi Pha

(2)

Hubei Xianglian Pharmaceu

(2)

Institute of Basic Medica

(2)

Institute of Materia Medi

(2)

Janssen Pharmaceutica

(2)

Jiangsu Hengrui Medicine;

(2)

Jiangsu Hengrui Pharmaceu

(2)

Jiangsu Jicui Advanced Fi

(2)

Jiangsu Runan Pharmaceuti

(2)

Jiangsu Simcere Pharmaceu

(2)

Jiangsu Zhiyuan Pharmaceu

(2)

Lianyungang Hai Heng Phar

(2)

Nanchang University

(2)

Ningxia Kingvit Pharmaceu

(2)

Recursion Pharmaceuticals

(2)

Regents of the University

(2)

(2)

Satellite New Material Re

(2)

Shaanxi University of Sci

(2)

Shandong First Medical Un

(2)

Shandong Kongshengtang Ph

(2)

Shandong Yuanke Biologica

(2)

Shanghai Inst Of Bio Phar

(2)

Shanghai Pailong Biotechn

(2)

Shanghai Tongji Hospital

(2)

Shanxi Weikangtang Chines

(2)

Shenzhen University

(2)

Sixpeaks Bio Ag

(2)

Sloan Kettering Inst For

(2)

Soochow University

(2)

Sparrow Pharmaceuticals

(2)

State Grid Shanghai Munic

(2)

Suzhou Gongkang Medicine

(2)

Suzhou Sancheng Pharmaceu

(2)

Taiho Pharmaceutical

(2)

The Mentholatum China Pha

(2)

Tianjin University; China

(2)

Univ Xinjiang Medical

(2)

University Liaoning Tradi

(2)

Yangtze River Delta Smart

(2)

Yunnan Zewei Pharmaceutic

(2)

Zhejiang For Your Health

(2)

Zhejiang Guobang Pharmace

(2)

Zhejiang Haizhixin Pharma

(2)

Zhejiang Ruian Hualian Ph

(2)

Zhejiang Zheneng Zhenhai

(2)

Zhongke Zhongshan Pharmac

(2)

4b Tech Beijing Co Limite

(1)

ADARx Pharmaceuticals

(1)

(1)

(1)

Access2bone Ip Bv

(1)

Accurie Bio Inc

(1)

Acon Therapeutics Inc

(1)

Adaxion Therapeutics Inc

(1)

Adc Therapeutics Sarl

(1)

Adicon Clinical Laborator

(1)

Adienne Pharma & Biotech

(1)

Adneuris Therapeutics Inc

(1)

Affiliated Hospital of Yu

(1)

Aldeyra Therapeutics Inc

(1)

(1)

Alveus Therapeutics Inc [

(1)

Alzecure Pharma Ab

(1)

Amber Therapeutics Pty Lt

(1)

Amgen Research (Munich)

(1)

Amphina Therapeutics Inc

(1)

Amsino Medical Kunshan Co

(1)

Amyra Biotech Ag

(1)

Anhui Anke Huaze Pharmace

(1)

Anhui Dihe Yongxin Pharma

(1)

Anhui Jianfeng Beika Phar

(1)

Anhui Medical University

(1)

Anhui Mingze Pharmaceutic

(1)

Anhui Sihuan Kebao Pharma

(1)

Anhui University of Chine

(1)

Anhui Yishun Plastic Ind

(1)

Anhui Zhifei Longcom Biop

(1)

Anhui Zoushifu Tcm Machin

(1)

Antares Therapeutics Inc

(1)

Antibe Therapeutics Inc

(1)

Apon Zhiyuan Brain Scienc

(1)

Arcutis Biotherapeutics

(1)

Asahi Chemical Ind [jp];

(1)

Ascendis Pharma Oncology

(1)

Askari Syed Hasan

(1)

Atom High Tech North Chin

(1)

(1)

Aveo Pharmaceuticals

(1)

(1)

(1)

Baifangkaiman Co Ltd

(1)

Bausch Health Ireland

(1)

Bausch+Stroebel

(1)

Baylor College of Medicin

(1)

Baz Therapeutics Inc

(1)

Beihang University

(1)

Beijing Chaoyang Hospital

(1)

Beijing Chest Hospital Af

(1)

Beijing Dongxuli Pharmace

(1)

Beijing Friendship Hospit

(1)

Beijing Gxak Tech Co Ltd

(1)

Beijing Heyanling Pharmac

(1)

Beijing Huanuo Xinde Tech

(1)

Beijing Huonland Pharmace

(1)

Beijing Inst Of Petrochem

(1)

Beijing Jianjian Medical

(1)

Beijing Jingfeng Pharmace

(1)

Beijing Kaiyingeling Biot

(1)

Beijing Kejie Huale Scien

(1)

Beijing Kuangwen Cancer M

(1)

Beijing Shenogen Pharmace

(1)

Beijing Stomatological Ho

(1)

Beijing Tongren Hospital,

(1)

Beijing University

(1)

Beijing University; Pekin

(1)

Beijing Xuanjingrui Pharm

(1)

Beijing Yinmei Future Bio

(1)

Beijing Yisheng Holding C

(1)

Beijing Zangwei Xinkang M

(1)

Beijing Zhongcheng Kangfu

(1)

Beijing Zhongpu Jishi Tra

(1)

Bennion Douglas [us]; Han

(1)

Betta Pharmaceuticals

(1)

Bexson Biomedical Inc [us

(1)

(1)

Biocon Biologics Ltd

(1)

Biohaven Therapeutics

(1)

(1)

Biom Enteva Europe Ag

(1)

(1)

Biosima Medicina Regenera

(1)

(1)

Boehringer Ingelheim Inte

(1)

Bone Therapeutics Inc

(1)

Bostal Drug Delivery Co L

(1)

Bounce Enterprises

(1)

Bozhou Jiahefu Pharmaceut

(1)

Bristol Myers Squibb

(1)

Camh [ca]; The Univ Court

(1)

Cangzhou Inst Of Technolo

(1)

Caraway Therapuetics Inc

(1)

Cassiopea S P A

(1)

Catalent Ontario Ltd

(1)

Cccc First Harbor Enginee

(1)

Celyntra Therapeutics Sa

(1)

Center For Drug Reevaluat

(1)

Centro De Ingenieria Gene

(1)

(1)

Chahar Right Front Banner

(1)

(1)

Changchun GeneScience Pha

(1)

Changchun Huanyu Jimin Ph

(1)

Changchun University of C

(1)

Changsha Meiri Ziyang Hea

(1)

Changxing Pharmaceutical

(1)

Changzhou STA Pharmaceuti

(1)

Changzhou Wujin People\'s

(1)

Changzhou Yabang Pharmace

(1)

Chengdao Zhiji Beijing Te

(1)

Chengdu Brilliant Pharmac

(1)

Chengdu Immuno Biopharmac

(1)

Chengdu Inst For Drug Con

(1)

Chengdu Kanghong Pharmace

(1)

Chengdu Mafeisan Medical

(1)

Chengdu North Petroleum E

(1)

Chengdu Shibekang Biomedi

(1)

Chengdu University of Tra

(1)

Chengdu Yazhong Bio Pharm

(1)

China Certification & Acc

(1)

China Inst Veterinary Dru

(1)

China Pharmaceutical Univ

(1)

China Rehabilitation Scie

(1)

China Resources Boya Bio-

(1)

China Resources Jiangzhon

(1)

China State Inst Of Pharm

(1)

Chinese People\'s Liberat

(1)

Chongqing Dianshengke Eng

(1)

Chongqing Hexijinhong Pha

(1)

Chongqing Medical Univers

(1)

Chongqing Shoujian Pharma

(1)

Chongqing University

(1)

Chongqing University of P

(1)

Chongqing Xianfeng Animal

(1)

Chongqing Xinyi Medical E

(1)

Chugai Seiyaku KK

(1)

Cinclus Pharma Holding AB

(1)

(1)

Coiled Therapeutics Inc [

(1)

(1)

Contemporary Amperex Tech

(1)

Contera Pharma As

(1)

Coultreon Biopharma Bv

(1)

(1)

Crinetics Pharmaceuticals

(1)

Cspc Zhongnuo Pharmaceuti

(1)

Cymbidium Medical Llc

(1)

D E Shaw Res Llc

(1)

Dacheng Suzhou Plastic Te

(1)

Daikin Ind Ltd [jp]; The

(1)

Dalai Nur Coal Industry

(1)

Dalian Minzu University

(1)

Dalian University of Tech

(1)

Dam Doctor Beijing Networ

(1)

Daozhen Autonomous County

(1)

Daxinganling Liwokang Pha

(1)

De Novo Biotherapeutics C

(1)

Deciphera Pharmaceuticals

(1)

(1)

Denka Co Limited

(1)

Dermatology Hospital of S

(1)

Disarm Therapeutics

(1)

Dong E E Jiao Co Ltd

(1)

Dongfang Hospital Of Beij

(1)

Dongguan Plater Hardware

(1)

Dr Dozo Laboratories

(1)

Drexel University

(1)

Drive Therapeutics Llc [u

(1)

ENSEM Therapeutics

(1)

East China University of

(1)

Eimeria Pty Ltd

(1)

Eisai R&D Management

(1)

Eleusis Therapeutics Us I

(1)

Eli Lilly And Co

(1)

Eli Lilly and Company; Un

(1)

(1)

Emit Imaging Inc

(1)

Empath Biosciences

(1)

Engine Biosciences Pte Lt

(1)

Enkang Pharmaceutical Tec

(1)

Enshi Miaomugong Traditio

(1)

Ensysce Biosciences Inc

(1)

(1)

Entrada Therapeutics

(1)

Environmental Tech & Engi

(1)

Epirium Bio Inc

(1)

(1)

(1)

Exini Diagnostics Ab [se]

(1)

Eye Hospital of China Aca

(1)

Fengdu Center For Disease

(1)

Fenix Res Labs Private Li

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First People\'s Hospital

(1)

Fond Toscana Life Science

(1)

Foshan Leawell Medical Te

(1)

Friendly Pharmaceutical

(1)

(1)

Fujian Cosunter Pharmaceu

(1)

Fujian Haicheng Medicine

(1)

Fujian Medical University

(1)

Fujian Zhong Nong Mu Bio

(1)

Fujifilm Corp [jp]; Sumit

(1)

Fuzhou Qinhe Pharmaceutic

(1)

Fuzhou University

(1)

Gaikwad Hanmantrao Ramdas

(1)

Ganjiang New Area Zhiyao

(1)

Gansu Bencaoyuan Chinese

(1)

Gansu Jiumei Cosmeceutica

(1)

Gansu Provincial Hospital

(1)

Gao Jian Rong [us]; Synlo

(1)

Gege Honglin Biological P

(1)

Genentech Inc [us]; Hoffm

(1)

Genentech; Hoffmann La Ro

(1)

(1)

Gezuntech Therapeutics Lt

(1)

(1)

GlaxoSmithKline Intellect

(1)

Glytech Inc [jp]; Figini

(1)

(1)

Guangdong Cell Biotechnol

(1)

Guangdong First Condor Bi

(1)

Guangdong Hongshanhu Phar

(1)

Guangdong Hospital of Tra

(1)

Guangdong Inst For Drug C

(1)

Guangdong Pharmaceutical

(1)

Guangdong Sake Biotech Co

(1)

Guangdong Second Traditio

(1)

Guangdong Xinbao Pharma T

(1)

Guangxi Guiwu Jinan Refri

(1)

Guangxi University of Chi

(1)

Guangxi Yanli Tech Resear

(1)

Guangzhou Baokang Pharmac

(1)

Guangzhou Changmaiyuan Bi

(1)

Guangzhou Dayi Pharmaceut

(1)

Guangzhou Hanguang Pharma

(1)

Guangzhou Inst Biomed & H

(1)

Guangzhou Lyvguo Fanghua

(1)

Guangzhou Medical Univers

(1)

Guangzhou National Labora

(1)

Guangzhou Ribobio Co Ltd

(1)

Guangzhou Sipei Pharmaceu

(1)

Guangzhou University of C

(1)

Guangzhou Wansi Biotechno

(1)

Guangzhou Wondfo Biotechn

(1)

Guangzhou Xuslan Whiteroc

(1)

Guangzhou Yuanbo Pharmace

(1)

Guilin University of Elec

(1)

Guizhou Chashoushan Senli

(1)

Guoke Wenzhou Research In

(1)

Guoyaojituan Tongjitang G

(1)

H Lee Moffitt Cancer Cent

(1)

Haijiang Invest Shandong

(1)

Hainan Hualon Pharmaceuti

(1)

Hainan Mengtuoluo Informa

(1)

Hainan Qianfan Pharmaceut

(1)

Hainan Senqi Pharmaceutic

(1)

Haisco Pharmaceutical Gro

(1)

Haisco Pharmaceutical Gro

(1)

Hangzhou Baichen Medical

(1)

Hangzhou Bailite Biopharm

(1)

Hangzhou Baixiangyuan Tec

(1)

Hangzhou China Resources

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou Heze Kunyuan Pha

(1)

Hangzhou Hoogbio Tech Co

(1)

Hangzhou Huqingyutang Co

(1)

Hangzhou Puyuan Biotechno

(1)

Hangzhou Sidate Biotechno

(1)

Hangzhou Taikang Pharmace

(1)

Hangzhou Yuanchang Medici

(1)

Hangzhou Zhongmei Huadong

(1)

Hangzhou Zhongmeihuadong

(1)

Harbin Medisan Pharmaceut

(1)

Harbin University of Scie

(1)

Hartis Pharma Sa

(1)

(1)

Health Decode Pharmacy Gu

(1)

Healvet Guangzhou Medical

(1)

Hebei Fengchi Biological

(1)

Hebei Hejia Pharmatech Gr

(1)

Hebei Renhe Yikang Pharma

(1)

Hebei University of Scien

(1)

Hebei University of Techn

(1)

Hebei Xingang Pharmaceuti

(1)

Hebei Yaoxing Pharmaceuti

(1)

Hebei Zhendaluo Biotechno

(1)

Hefei Institutes of Physi

(1)

Hefei Natural Time Pharma

(1)

Hefei Tiangang Immunology

(1)

Heilongjiang Fisheries Re

(1)

Heilongjiang University

(1)

Heilongjiang Wangda Chine

(1)

Heilongjiang Yujie Biolog

(1)

Henan Academy of Medical

(1)

Henan Baitahan Pharmaceut

(1)

Henan Celnovtebio Biotech

(1)

Henan Hanyi Daily Chemica

(1)

Henan Houyi Bioengineerin

(1)

Henan Linlai Biotechnolog

(1)

Henan Tianzhengu Pharmace

(1)

Henan University of Techn

(1)

(1)

Hitachi Channel Solutions

(1)

Hoffmann La Roche [ch]; R

(1)

Hongjitang Pharmaceutical

(1)

Hospital Affiliated To Fu

(1)

Huabo Biopharm Shanghai C

(1)

Huangshan University

(1)

Huayi Taikang Pharmaceuti

(1)

Hubei Baoshengde Pharmace

(1)

Hubei Bio Pharmaceutical

(1)

Hubei Chengde Pharmaceuti

(1)

Hubei Dadingshan Pharmace

(1)

Hubei Gongtong Zaiti Phar

(1)

Hubei Hongyuan Pharmaceut

(1)

Hubei Meifeng New Mat Co

(1)

Hubei Runkang Yaogushan C

(1)

Hubei University of Arts

(1)

Hubei University of Techn

(1)

Hubei Wudang Antai Pharma

(1)

Hubei Xintiankang Pharmac

(1)

Huizhou Feinaier Lubrican

(1)

Human Bioscience Inc

(1)

Humanitas Mirasole S P A

(1)

Hunan Academy of Chinese

(1)

Hunan Bagang Biotechnolog

(1)

Hunan Changle New Mat Co

(1)

Hunan Kelun Pharmaceutica

(1)

Hunan Maiya Pharmaceutica

(1)

Hunan Taiyang Pharmaceuti

(1)

Hunan Tobacco Co Yongzhou

(1)

Hunan Xingyuan Tech Co Lt

(1)

Hunan Zhenqing Pharmaceut

(1)

I Mab Biopharma Us Ltd [u

(1)

Ibsa Inst Biochimique Sa

(1)

Immvirx Pty Ltd

(1)

Imperial College Innovati

(1)

Impetis Biosciences Ltd

(1)

(1)

Increase Hong Kong Innova

(1)

Inner Mongolia Mengyite D

(1)

Inner Mongolia University

(1)

(1)

Inst For Cancer Research

(1)

Inst Nat Sante Rech Med [

(1)

Inst Nat Sante Rech Med [

(1)

Inst Nat Sante Rech Med;

(1)

Inst Of Microbiology Heil

(1)

Inst Pasteur [fr]; Centre

(1)

Institut National De La S

(1)

Institut National De La S

(1)

Institut National De La S

(1)

Institut National De La S

(1)

Institute Military Medici

(1)

Institute of Radiation Me

(1)

International Physical Di

(1)

Intervet Int B V [nl]; In

(1)

Intree Biosciences Inc

(1)

Ionis Pharmaceuticals

(1)

Isanaka Ramakrishna Reddy

(1)

Itf Res Pharma S L U

(1)

Jagielski Jordan O [us];

(1)

(1)

Jiangsu Aosaikang Pharm C

(1)

Jiangsu Atasi Biotechnolo

(1)

Jiangsu Chenxing Pharmace

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengxin Pharmaceu

(1)

Jiangsu Inst Parasitic Di

(1)

Jiangsu Jevkev Medtec Co

(1)

Jiangsu Jichun Medical De

(1)

Jiangsu Jingchan Pharmace

(1)

Jiangsu Jinwu Medical Tec

(1)

Jiangsu Lianshui Pharmace

(1)

Jiangsu Nhwa Pharmaceutic

(1)

Jiangsu Nhwa Pharmaceutic

(1)

Jiangsu Ruiyuan Biotechno

(1)

Jiangsu Simcere Pharm Co

(1)

Jiangsu Tasly Diyi Pharma

(1)

Jiangsu Wuhua Pharmaceuti

(1)

Jiangsu Yaohai Bio Pharma

(1)

Jiangsu Yongan Pharmaceut

(1)

Jiangsu Yutian Pharmaceut

(1)

Jiangxi Baisikangrui Phar

(1)

Jiangxi Kaixin Biomedical

(1)

Jiangxi Synergy Pharmaceu

(1)

Jiangxi Universe Pharmace

(1)

Jiangxi Xinshengming Phar

(1)

Jiangxi Yizhichu Medical

(1)

Jiangyin Feijiang Plastic

(1)

Jiangyin Tianjiang Pharma

(1)

Jianmin Pharmaceutical Gr

(1)

Jiaoka Pharmaceutical Tec

(1)

Jiaying University

(1)

Jilin Mufeng Pharmaceutic

(1)

Jilin Sanyi Pharmaceutica

(1)

Jilin Tiancheng Pharmaceu

(1)

Jilin Xianfeng Tech Pharm

(1)

Jilin Xidian Pharmaceutic

(1)

Jina Pharmaceuticals Inc

(1)

Jinan Jiulong Pharmaceuti

(1)

Jinan Jurentang Aimin Pha

(1)

Jinan University

(1)

Jinan University; Univers

(1)

Jinan University; Zhongke

(1)

Jining Saite Machinery Co

(1)

Jining Shenzhou Pharmaceu

(1)

Jinzhou Ahon Pharmaceutic

(1)

Jiuhua & Huayuan Pharmace

(1)

Jiyang College Of Zhejian

(1)

Jnd Therapeutics Inc

(1)

Joint Stock Co Generium

(1)

Junlin Pharmaceutical Tec

(1)

Juxian Longshan Animal Hu

(1)

(1)

Kangde Shenzhen Biotechno

(1)

Kanglin Bio Tech Hangzhou

(1)

Kate Therapeutics Inc

(1)

Katholieke Univ Leuven Ku

(1)

(1)

Kazm Pharmaceuticals Inc

(1)

Kerry Group Services Inte

(1)

Keruidi Nanjing Pharmaceu

(1)

Ketim Holdings Pty Ltd

(1)

Kobayashi Pharmaceutical

(1)

Koninklijke Philips

(1)

Kunming Municipal Hospita

(1)

Kvr Pharmaceuticals Inc

(1)

Kyowa Hakko Kirin Co Ltd

(1)

Kyowa Pharma Chemical Co

(1)

(1)

LTS Lohmann Therapie-Syst

(1)

LTZ Therapeutics

(1)

Laekna Therapeutics, Shan

(1)

Lanzhou University; Longg

(1)

(1)

Lask Pharma Inc

(1)

Lb Pharmaceuticals Inc

(1)

(1)

Lianyungang Branch Of Jia

(1)

Liaoning Xinshidai Biomed

(1)

Lifotronic Tech Co Ltd

(1)

Lingnan Traditional Chine

(1)

(1)

Livzon Pharmaceutical Gro

(1)

Luoyang Institute of Scie

(1)

Luoyang Tianjiang Fine Ch

(1)

Luoyang Wokang Pharmaceut

(1)

Mabwell Shanghai Bioscien

(1)

Maiva Pharma Private Ltd

(1)

Massachusetts Eye and Ear

(1)

Max-Planck-Gesellschaft z

(1)

Mebias Discovery Inc

(1)

Medicenna Therapeutics In

(1)

Meiji; National Univ Corp

(1)

Meilan Hangzhou Pharmaceu

(1)

(1)

(1)

Merck Sharp & Dohme

(1)

Merck Sharp & Dohme Llc [

(1)

Metimedi Pharmaceuticals

(1)

Minjiang University

(1)

Minxian Jinkang Tradition

(1)

Mitsubishi Corporation Li

(1)

Monpeptide Pharmaceutical

(1)

Monte Rosa Therapeutics A

(1)

Muen Pharmaceutical Equip

(1)

Murakami Hiroshi

(1)

Myris Therapeutics Inc

(1)

(1)

Nanfang Hospital

(1)

Nanfang Hospital, Souther

(1)

Nanjing Academy Of Ecolog

(1)

Nanjing Chemo Pharmaceuti

(1)

Nanjing Chia-Tai Tianqing

(1)

Nanjing Drum Tower Hospit

(1)

Nanjing Hailing Pharmaceu

(1)

Nanjing Hairun Pharmaceut

(1)

Nanjing Huawei Medical Eq

(1)

Nanjing Leizheng Pharmace

(1)

Nanjing Mainuowei Pharmac

(1)

Nanjing Medical Universit

(1)

Nanjing Nanda Pharmaceuti

(1)

Nanjing Normal Univ Taizh

(1)

Nanjing Polytechnic Insti

(1)

Nanjing Sinuo New Drug Re

(1)

Nanjing Ximo Sibo Detecti

(1)

Nanjing Youmeng Biotechno

(1)

Nanjing Zhongke Pharmaceu

(1)

Nanoform Finland Oyj [fi]

(1)

Nantong Tumor Hospital; N

(1)

Nantong Yishide Medical A

(1)

Nasofeide Shanghai Pharma

(1)

Nat Power Harbin Thermoel

(1)

Neurocrine Biosciences In

(1)

(1)

New Product Innovation Ll

(1)

NewAmsterdam Pharma

(1)

Nihon Pharmaceutical Co L

(1)

Ningbo Inst Materials Tec

(1)

Ningbo Sailefu Sheet Mate

(1)

Ningxia Changsheng Pharma

(1)

Ningxia Hengkang Technolo

(1)

Ningxia Tianxin Pharmaceu

(1)

Ningxia University; Ningx

(1)

Nora Therapeutics Inc

(1)

North Carolina State Univ

(1)

North Sichuan Medical Col

(1)

Northeast Agricultural Un

(1)

Ocean University China

(1)

Octane Innovation Inc

(1)

Ohio Sate Innovation Foun

(1)

Ohio State Innovation Fou

(1)

Onconic Therapeutics Inc

(1)

Oppilan Pharma Ltd

(1)

Otsuka Pharmaceutical

(1)

Oxford Univ Innovation Lt

(1)

Oyster Point Pharma

(1)

PLA Air Force Medical Uni

(1)

Panke Pharmaceutical Pack

(1)

Peking Union Medical Coll

(1)

Peking Univ Sixth Hospita

(1)

Peking University People\

(1)

Petroleo Brasileiro

(1)

(1)

Picavison Therapeutics In

(1)

Polymer Science And Tech

(1)

Porton Pharma Solutions

(1)

Precomb Therapeutics Ag

(1)

(1)

Primelink Biotherapeutics

(1)

Princeton University

(1)

Protomo Tech Inc

(1)

Proya Cosmetics; Shanghai

(1)

Puji Biotechnology Taizho

(1)

Purdue Research Foundatio

(1)

Qilu Pharmaceutical Inner

(1)

Qingdao Central Hospital

(1)

Qinghai Tibetan Medicine

(1)

Qinhuangdao Huakan Geolog

(1)

(1)

Quorum Innovations Inc

(1)

R P Scherer Technologies

(1)

ROHTO Pharmaceutical

(1)

Ratio Therapeutics Inc

(1)

RaySearch Laboratories

(1)

(1)

Relevium Medical

(1)

Replicot Biosciences Inc

(1)

Research & Business Found

(1)

Ricoh Co Ltd [jp]; Shizuo

(1)

Riconpharma Llc

(1)

Rigerna Therapeutics Beij

(1)

Rocket Science Health

(1)

Ruijin Hospital Affiliate

(1)

Ruiqi Suzhou Biological T

(1)

SPR Therapeutics

(1)

Sanner Pharmaceutical & M

(1)

(1)

(1)

Sanwei Industrial Technol

(1)

Sartorius Stedim Biotech

(1)

Sartorius Xell Gmbh

(1)

Sato Pharmaceutical Co Lt

(1)

Second Hospital Iaxing

(1)

Selenium Life Medical Res

(1)

(1)

Senkapharmacy Co Ltd

(1)

Shaanxi Mai Yuan Biotechn

(1)

Shaanxi University of Chi

(1)

Shaanxi Yuci Guocui Chine

(1)

Shandong Anxin Pharmaceut

(1)

Shandong Aojing Biologica

(1)

Shandong Chuancheng Pharm

(1)

Shandong Dehao Chemical C

(1)

Shandong Fanzhi Zhizao Ph

(1)

Shandong Fengjin Pharmace

(1)

Shandong Institute of Med

(1)

Shandong Jianyihong Biolo

(1)

Shandong Kexin Pharmaceut

(1)

Shandong Liaocheng Ehua P

(1)

Shandong Nhu Pharmaceutic

(1)

Shandong Qingke Agricultu

(1)

Shandong Ruian Optoelectr

(1)

Shandong Sanrun Biotechno

(1)

Shandong Second People\'s

(1)

Shandong Shenlian Biologi

(1)

Shandong Shijitong Pharma

(1)

Shandong Shuojing Biologi

(1)

Shandong University

(1)

Shandong Xianglong Pharma

(1)

Shandong Xinhe Biological

(1)

Shandong Xinzuobiao Pharm

(1)

Shandong Xulie Biotechnol

(1)

Shandong Yirentang Pharma

(1)

Shandong Yuanlitai Pharma

(1)

Shanghai 10th People\'s H

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Aucta Pharmaceut

(1)

Shanghai Best Link Biosci

(1)

Shanghai Changxing Ocean

(1)

Shanghai Chengfan Pharmac

(1)

Shanghai Clinical Res Cen

(1)

Shanghai Dermatology Hosp

(1)

Shanghai Dongfulong Pharm

(1)

Shanghai Fengxian Central

(1)

Shanghai Haini Pharmaceut

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Infectious And I

(1)

Shanghai Inst For Drug Co

(1)

Shanghai Inst Of Nutritio

(1)

Shanghai Inst Technology;

(1)

Shanghai Institute of Mat

(1)

Shanghai Jianyi Tengchuan

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiaotong Univeri

(1)

Shanghai Jiyun Biotechnol

(1)

Shanghai Qilu Pharmaceuti

(1)

Shanghai Ruibo Shenqiu Bi

(1)

Shanghai Senhui Medicine

(1)

Shanghai Shali Biotechnol

(1)

Shanghai Sinofluoro Scien

(1)

Shanghai Skin Disease Hos

(1)

Shanghai Syntheall Pharma

(1)

Shanghai Wanheyuan Biotec

(1)

Shanghai Weizhenzi Biotec

(1)

Shanghai Wennai Medical T

(1)

Shanghai Yingli Pharmaceu

(1)

Shangluo Animal Husbandry

(1)

Shanxi Dongyi Coal Power

(1)

Shanxi University of Chin

(1)

Shenzhen Agricultural Gen

(1)

Shenzhen Eye Hospital She

(1)

Shenzhen Hightide Biophar

(1)

Shenzhen Laimang Biotechn

(1)

Shenzhen Maternity & Chil

(1)

Shenzhen Newdel Biotech

(1)

Shenzhen Shankang Pharmac

(1)

Shihezi University

(1)

Shijiazhuang Jiuwutang Bi

(1)

Shijiazhuang Jiuzhou Vete

(1)

Shijiazhuang Vocational T

(1)

(1)

Sichuan Cancer Hospital

(1)

Sichuan Changhong Pharmac

(1)

Sichuan Huiyu Haiyue Phar

(1)

Sichuan Huiyu Yueying Pha

(1)

Sichuan Neo Green Pharmac

(1)

Sichuan Pharmaceutical; C

(1)

Sichuan Qingmu Pharmaceut

(1)

Sichuan Renan Pharmaceuti

(1)

Sichuan Tianfu Shenlong T

(1)

Sichuan University

(1)

Sichuan Weierkang Animal

(1)

Sichuan Zengshi Yudi Tech

(1)

Sichuan Zitongong Pharmac

(1)

Simcere Pharmaceutical Co

(1)

Simcere Zaiming Pharmaceu

(1)

Singh Ash [us]; Wang Pei

(1)

Singla Ashwani [in]; Kaur

(1)

Sintef Tto As [no]; Oslo

(1)

(1)

(1)

(1)

Sonoma Biotherapeutics

(1)

South Central University

(1)

Southern Medical Universi

(1)

Southern Methodist Univ

(1)

Southwest Medical Univers

(1)

Southwest Petroleum Unive

(1)

Standard Pharmaceutical R

(1)

State Grid Jilin Electric

(1)

State Petroleum Pipeline

(1)

Suli Pharmaceutical Tech

(1)

Summit Therapeutics Inc

(1)

Sun Yat-sen University

(1)

Sunbeam Therapeutics Inc

(1)

Suzhou Boyang Chemical

(1)

Suzhou First Pharmaceutic

(1)

Suzhou Fuente Pharmaceuti

(1)

Suzhou Genhouse Bio

(1)

Suzhou Homesun Pharmaceut

(1)

Suzhou Jingye Medicine &

(1)

Suzhou Kintor Pharmaceuti

(1)

Suzhou Liming Tech Co Ltd

(1)

Suzhou Maoxing Biological

(1)

Suzhou Merna Therapeutics

(1)

Suzhou Nuojiebei Biotechn

(1)

Suzhou Ribo Life Science

(1)

Suzhou Shanbai Biotechnol

(1)

Suzhou Vocational Health

(1)

Suzhou Xingyao Kunze Biol

(1)

Symbio Pharmaceuticals Lt

(1)

Symbiotica Therapeutics S

(1)

Synbiotech Biotechnology

(1)

Synnovation Therapeutics

(1)

T C Uskudar Univ

(1)

(1)

Taihe Pharmaceutical Weih

(1)

Taiji Group Sichuan Nanch

(1)

Taizhou University

(1)

Takeda Pharmaceutical Co

(1)

Tanabe Pharma Corp

(1)

Tech Holdings Corp

(1)

Tech Holdings Corporation

(1)

Technikum Laubholz Gmbh

(1)

(1)

Telix Pharmaceuticals Inn

(1)

Telum Therapeutics S L

(1)

Tencent Technology, Shenz

(1)

Terra Lab Int D O O

(1)

(1)

The Affiliated Hospital o

(1)

The Catholic University o

(1)

The Feinstein Inst For Me

(1)

The First People\'s Hospi

(1)

The Hong Kong Polytechnic

(1)

The Inst Of Cancer Resear

(1)

The People\'s Hospital of

(1)

The Royal Veterinary Coll

(1)

The Second Affiliated Hos

(1)

The Second Affiliated Hos

(1)

The Second Hospital of An

(1)

The Second Xiangya Hospit

(1)

The Third Affiliated Hosp

(1)

The University of Tokyo

(1)

Third Inst Of Oceanograph

(1)

Tiangong Biotechnology Ti

(1)

Tianjin Bioscience Co Ltd

(1)

Tianjin Feiman Power Tech

(1)

Tianjin Inst Pharmaceutic

(1)

Tianjin Polytechnic Unive

(1)

Tianjin Sendi Hengsheng T

(1)

Tianjin University Resear

(1)

Tianjin University Resear

(1)

Tianjin University Zhejia

(1)

Tianjin University of Sci

(1)

Tianjin University; Harbi

(1)

Tianjin University; Offsh

(1)

Tianjin University; Tianj

(1)

Tianjin University; Tianj

(1)

Tianjin University; Tianj

(1)

Tianjin University; Tianj

(1)

Tianjin University; Tianj

(1)

Tianjin University; Unive

(1)

Tianjin University; Xinhe

(1)

Tianjin University; Yunji

(1)

Tiger Wound Care Medical

(1)

Tlc Nanjing Pharmaceutica

(1)

Tohoku University

(1)

Tonghua Wantong Pharmacy

(1)

Topfond Pharma Co Ltd

(1)

Totus Medical Ab

(1)

Totus Medicines Inc

(1)

Traditional Chinese Medic

(1)

Truking Feiyun Pharmaceut

(1)

Truking Jingbang Clean En

(1)

Tsinghua University

(1)

Tsinghua University; Beij

(1)

Tsinghua University; East

(1)

Tufts Medical Center

(1)

UCB Biopharma SPRL

(1)

UNM Rainforest Innovation

(1)

Ucb Biopharma Srl [be]; S

(1)

Uif Univ Industry Foundat

(1)

United Bio-Shanghai and S

(1)

Univ Lanzhou Arts And Sci

(1)

Univ New York State Res F

(1)

Univ Shandong Medical

(1)

Univ Shanghai Medical & H

(1)

University Hubei Chinese

(1)

University Yunnan Traditi

(1)

University of Houston Sys

(1)

University of Macau

(1)

University of Nebraska–

(1)

University of North Texas

(1)

University of Pittsburgh

(1)

University of Virginia Pa

(1)

Utr Biotech Ltd

(1)

(1)

Vertex Pharmaceuticals

(1)

Viiv Healthcare UK No 5

(1)

Viiv Healthcare Uk No 3 L

(1)

Vivas Therapeutics Inc

(1)

(1)

(1)

(1)

Weisheng Pharmaceutical C

(1)

Wenlan Pharmaceutical Suz

(1)

Wenzhou Tianyi Plastic Co

(1)

West Pharmaceutical Servi

(1)

Whan In Pharmaceutical Co

(1)

Wisconsin Alumni Res Foun

(1)

Wuhan Aofei Tech Co Ltd

(1)

Wuhan Hospital of Traditi

(1)

Wuhan Humanwell Pharmaceu

(1)

Wuhan Runfuling Tech Co L

(1)

Wuhan Shiji Pharmaceutica

(1)

Wuhan University of Techn

(1)

Wuhan Yuxiang Medicine Te

(1)

Wuxi Further Pharmaceutic

(1)

Wuxi Jida Pharmaceutical

(1)

Wuxi Pneumatic Technical

(1)

Wuxi Shengji Pharmaceutic

(1)

Wuxi Youleimu Tech Co Ltd

(1)

Wuxi Zhongyi Chemical Pha

(1)

Xeek Xiamen Medical Instr

(1)

Xiamen Zhengyuan Environm

(1)

Xiangya Hospital Central

(1)

Xiantao Xianyi Packaging

(1)

Xiaoguang New Material Te

(1)

Xinhua Hospital affiliate

(1)

Xinjiang Shalemai Health

(1)

Xinqikang Pharmaceutical

(1)

Xinsaidao Tianjin Tech De

(1)

Xintuoyang Biological Eng

(1)

Xinxiang Jingquan Biotech

(1)

Xuanwu Hospital, Capital

(1)

Yale Univ [us]; Biohaven

(1)

Yanbian University

(1)

Yancheng Guanghao Welding

(1)

Yancheng Inst Technology

(1)

Yangling Charisma Bio Pha

(1)

Yangtze Normal University

(1)

Yangtze River Pharmaceuti

(1)

Yangzhou Qinyuan Pharmace

(1)

Yanshan Animal Health Sup

(1)

Yantai Inst Of Coastal Zo

(1)

Yantai Lannacheng Biotech

(1)

Yantai Pharmaceutical Cre

(1)

Yichang Humanwell Pharmac

(1)

Yigu Chuzhou Aviation Med

(1)

Yingxi Intelligent Tech I

(1)

Yingxi Intelligent Tech S

(1)

Yissum Research Developme

(1)

(1)

Youcare Pharmaceutical Gr

(1)

Yuanda Pharmaceutical Xia

(1)

Yunnan Jinqi Pharmaceutic

(1)

Yunnan Nanyao Pharmaceuti

(1)

Yuzhou Baicaohui Pharmace

(1)

Zesheng Biotech Co Ltd

(1)

(1)

Zhaoke Pharmaceutical Hef

(1)

Zhejiang Changbei Biology

(1)

Zhejiang Hanwei Tech Co L

(1)

Zhejiang Heli Xinjian Pha

(1)

Zhejiang Hisoar Pharmaceu

(1)

Zhejiang Huahai Pharm Co

(1)

Zhejiang Huahai Pharmaceu

(1)

Zhejiang Jianfeng Pharmac

(1)

Zhejiang Jinan Pharmaceut

(1)

Zhejiang Novus Pharmaceut

(1)

Zhejiang Police Vocationa

(1)

Zhejiang Saimo Pharmaceut

(1)

Zhejiang Shuangheng Healt

(1)

Country

X

China Patent News

European Patent News

WIPO Patent News

Status

X

1 - 100 of 1344 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Suzhou Shanbai Biotechnology Co Ltd Seeks Patent for FMT Preparation for Treating Lung Cancer as Well as Screening Method and Application of Fmt Preparation

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Suzhou Shanbai Biotechnology Co Ltd has sought patent for FMT Preparation for Treating Lung Cancer as Well as Screening Method and Application of Fmt Preparation. This invention was developed by Wang Wanchang and Cai Jun. The patent application number is CN202610224532 20260225. The patent publication numb..

Qingdao Central Hospital Of Rehabilitation University Applies for Patent on Tumor Detection Marker and Application Thereof in Drug Preparation

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Qingdao Central Hospital Of Rehabilitation University has applied Chinese patent for Tumor Detection Marker and Application Thereof in Drug Preparation. Miao Hongxia, Wang Shuhui, Song Ning and Gao Jing developed it. The patent application number is CN202610241289 20260228. The patent publication number is..

First Affiliated Hospital of Chongqing Medical University and BOE Technology Group Submit Chinese Patent Application for Mirna Biomarkers, Compositions, Kits, Uses and Methods Ther..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- First Affiliated Hospital of Chongqing Medical University and BOE Technology Group have submitted a patent application for Mirna Biomarkers, Compositions, Kits, Uses and Methods Thereof. This invention was developed by He Chaohui, Zhao Zijian, Xiang Shuyue, Liu Mengjia, Tan Jiahe, Liu Zhiqiang, Ye Bangquan an..

Jiangsu Jicui Advanced Fiber Materials Research Inst Co Ltd Submits Chinese Patent Application for Light-triggered Slow-release Traditional Chinese Medicine Antibacterial and Anti-..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Jiangsu Jicui Advanced Fiber Materials Research Inst Co Ltd has submitted a patent application for Light-triggered Slow-release Traditional Chinese Medicine Antibacterial and Anti-mosquito Polyamide Master Batch as Well as Preparation Method and Application Thereof. This invention was developed by Qin Zixin, ..

Tianjin University of Science & Technology Seeks Patent for High-performance Composite Plant Fiber Foaming Material as Well as Preparation Method and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Tianjin University of Science & Technology has sought patent for High-performance Composite Plant Fiber Foaming Material as Well as Preparation Method and Application Thereof. This invention was developed by Liu Liqin, Cheng Zhengbai, Song Shaodong and An Xingye. The patent application number is CN2026105362..

Cangzhou Institute Of Technology Tianjin University Submits Chinese Patent Application for Preparation Method of Polyimide-based Phase Change Aerogel

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Cangzhou Institute Of Technology Tianjin University has submitted a patent application for Preparation Method of Polyimide-based Phase Change Aerogel. This invention was developed by Tan Yan, Guo Jie, Han Na and Sha Qiankun. The patent application number is CN202610204018 20260212. The patent publication n..

State Intellectual Property Office of China Publishes North Sichuan Medical College Patent Application for Colorful Cocoon-based Sericin Microsphere as Well as Preparation Method a..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published North Sichuan Medical College patent application for Colorful Cocoon-based Sericin Microsphere as Well as Preparation Method and Application Thereof. The invention was developed by Meng Zhijun, Wang Tianliang and Zhang Chuan. The patent application ..

State Intellectual Property Office of China Receives University Hubei Chinese Medicine Patent Application for Chrysanthemum Indicum Extract and Application Thereof in Cosmetics

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received University Hubei Chinese Medicine patent application for Chrysanthemum Indicum Extract and Application Thereof in Cosmetics. Xu Kang and Wang Chunli developed the invention. The patent application number is CN202610391943 20260327. The patent publica..

State Intellectual Property Office of China Releases East China University of Science and Technology and Shanghai Jiao Tong University Patent Application for Protein Stability Dete..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released East China University of Science and Technology and Shanghai Jiao Tong University patent application for Protein Stability Detection Probe Based on Ascorbic Acid Peroxidase 2 and Application Thereof. This invention was developed by Ruan Qingyun, Quan Sh..

State Intellectual Property Office of China Releases Hefei Tiangang Immunology Pharmaceutical Co Ltd Patent Application for CD3 and Mica Bispecific Antibody and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Hefei Tiangang Immunology Pharmaceutical Co Ltd patent application for CD3 and Mica Bispecific Antibody and Application Thereof. This invention was developed by Li Yangyang, Cao Guoshuai and Wu Yuwei. The patent application number is CN202511785905 2..

Shandong Yuanke Biological Tech Co Ltd Applies for Patent on Detection Kit Based on Beta-trace Protein Monoclonal Antibody and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shandong Yuanke Biological Tech Co Ltd has applied Chinese patent for Detection Kit Based on Beta-trace Protein Monoclonal Antibody and Application Thereof. Sun Bo, Cai Lihai, Lin Guimei, Jiang Jiali, Zhou Xiaojin and Qiu Shengnan developed it. The patent application number is CN202610539597 20260422. The ..

State Intellectual Property Office of China Publishes Jiangsu Atasi Biotechnology Co Ltd Patent Application for Anti-human Cd8 Rabbit Recombinant Monoclonal Antibody and Applicatio..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Jiangsu Atasi Biotechnology Co Ltd patent application for Anti-human Cd8 Rabbit Recombinant Monoclonal Antibody and Application Thereof. The invention was developed by Ding Wei, Shao Qiyu, Ding Yaqing, Yao Bixiao, Chen Si and He Lin. The patent appl..

Nanjing Sinuo New Drug Res And Development Co Ltd Seeks Patent for Anti-fgfr2iiib Specific Antibody

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Nanjing Sinuo New Drug Res And Development Co Ltd has sought patent for Anti-fgfr2iiib Specific Antibody. This invention was developed by Wang Zhichao and Mei Yan. The patent application number is CN202411674159 20241121. The patent publication number is CN122080206 (A). International Patent Classification..

State Intellectual Property Office of China Releases Mabwell Shanghai Bioscience and Jiangsu T Mab Biopharma Co Ltd Patent Application for TNFR2 Antibody and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Mabwell Shanghai Bioscience and Jiangsu T Mab Biopharma Co Ltd patent application for TNFR2 Antibody and Application Thereof. This invention was developed by Ji Jiali, Wang Rui, Peng Wenjing, Gui Xun and Ren Hongyuan. The patent application number is..

State Intellectual Property Office of China Publishes Shandong Yuanke Biological Tech Co Ltd Patent Application for Antioxidant Low-density Lipoprotein Monoclonal Antibody and Appl..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Shandong Yuanke Biological Tech Co Ltd patent application for Antioxidant Low-density Lipoprotein Monoclonal Antibody and Application Thereof. The invention was developed by Sun Bo, Cai Lihai, Lin Guimei, Jiang Jiali, Zhou Xiaojin and Qiu Shengnan. ..

State Intellectual Property Office of China Receives Beijing Subenyuanhe Biotechnology Co Ltd Patent Application for Monoclonal Antibody for Resisting Avian Influenza Virus H7 Subt..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Beijing Subenyuanhe Biotechnology Co Ltd patent application for Monoclonal Antibody for Resisting Avian Influenza Virus H7 Subtype Hemagglutinin Protein and Application. Li Yue, Sun Yutian, Su Du, Lu Shuai, Zhong Ming and Qin Kun developed the invention..

State Intellectual Property Office of China Receives Harbin Veterinary Research Institute Caas Harbin Branch Of China Animal Health And Epidemiology Center Patent Application for B..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Harbin Veterinary Research Institute Caas Harbin Branch Of China Animal Health And Epidemiology Center patent application for Bovine Ephemeral Fever Virus Competitive Monoclonal Antibody and Application Thereof in Construction of Competitive Elisa Kit. ..

Harbin Veterinary Research Institute Caas Harbin Branch Of China Animal Health And Epidemiology Center Files Chinese Patent Application for Monoclonal Antibody of Feline Caliciviru..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Harbin Veterinary Research Institute Caas Harbin Branch Of China Animal Health And Epidemiology Center has filed a patent application for Monoclonal Antibody of Feline Calicivirus, Kit and Application Thereof. This invention was developed by Zhang He, Wang Wei, Li Changwen and Xia Changyou. The patent appl..

China Institute Veterinary Drugs Control Seeks Patent for Monoclonal Antibody for Resisting Duck Adenovirus 3 Type Fiber2 Protein and Application of Monoclonal Antibody for Detecti..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- China Institute Veterinary Drugs Control has sought patent for Monoclonal Antibody for Resisting Duck Adenovirus 3 Type Fiber2 Protein and Application of Monoclonal Antibody for Detecting or Identifying Duck Adenovirus 3 Type. This invention was developed by Liu Dan, Kong Dongni, Xue Qi, Wang Jia, Wu Hongju, ..

State Intellectual Property Office of China Publishes Yantai Inst Of Coastal Zone Research Chinese Academy Of Sciences Patent Application for Sea Lion Source Antibacterial Peptide ..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Yantai Inst Of Coastal Zone Research Chinese Academy Of Sciences patent application for Sea Lion Source Antibacterial Peptide for Selectively Targeting Gram Negative Drug-resistant Bacteria and Application of Sea Lion Source Antibacterial Peptide. The ..

State Intellectual Property Office of China Receives Jiangsu Yaohai Bio Pharmaceutical Co Ltd Patent Application for Recombinant Mussel-like Mucin and Coding Gene and Application T..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Jiangsu Yaohai Bio Pharmaceutical Co Ltd patent application for Recombinant Mussel-like Mucin and Coding Gene and Application Thereof. Zuo Tao, Lyu Guangxin, Wang Manchao and Liu Li developed the invention. The patent application number is CN20251192..

State Intellectual Property Office of China Releases Dalian University of Technology Patent Application for High-flux Toxicity Pre-evaluation Substitution Method Based on Neuropath..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Dalian University of Technology patent application for High-flux Toxicity Pre-evaluation Substitution Method Based on Neuropathy Target Esterase Target. This invention was developed by Liu Lin, Chen Haonan, Zhang Han, Yang Jun and Qu Mingbo. The patent..

Hubei Gongtong Zaiti Pharmaceutical Research Institute Co Ltd Seeks Patent for Preparation Method of Cholanol Ketone

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Hubei Gongtong Zaiti Pharmaceutical Research Institute Co Ltd has sought patent for Preparation Method of Cholanol Ketone. This invention was developed by Zheng Xiangyi, Cheng Han, Xi Zubin, Yu Peilin, Xu Can, Yao Licheng, Chen Yi and Li Minglei. The patent application number is CN202610193903 20260210. Th..

Xintuoyang Biological Engineering Submits Chinese Patent Application for Method for Efficiently Converting 7-dehydrocholesterol into Vitamin D3

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Xintuoyang Biological Engineering has submitted a patent application for Method for Efficiently Converting 7-dehydrocholesterol into Vitamin D3. This invention was developed by Lu Zhongtan, Zhu Tengyue, Chen Gaoming, Wu Jianwei, Chen Yajun, Wang Xingang, Cui Fengxia, Chen Hongzhan, Shi Lijun, Zhang Jianguo, K..

Shanghai Infectious Disease and Biological Safety Research Institute Files Chinese Patent Application for Preparation and Application of Coxsackie Virus A6 Type Attenuated Live Vac..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shanghai Infectious Disease and Biological Safety Research Institute has filed a patent application for Preparation and Application of Coxsackie Virus A6 Type Attenuated Live Vaccine Vector. This invention was developed by Zhang Chao and Liu Kexin. The patent application number is CN202610248203 20260302. ..

Qilu Pharmaceutical Inner Mongolia Co Ltd Seeks Patent for Streptomyces Promoter Selection Marker and Application

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Qilu Pharmaceutical Inner Mongolia Co Ltd has sought patent for Streptomyces Promoter Selection Marker and Application. This invention was developed by Cao Xiaoyu, Liu Zuxin, Zhang Qinghui, Zhang Zhilong, Zhao Yajun, Han Jun and Dang Fujun. The patent application number is CN202610550814 20260424. The pate..

State Intellectual Property Office of China Publishes Shanghai Jiao Tong University Patent Application for D-lactic Dehydrogenase, Engineering Strain Containing D-lactic Dehydrogen..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Shanghai Jiao Tong University patent application for D-lactic Dehydrogenase, Engineering Strain Containing D-lactic Dehydrogenase and Construction and Application of D-lactic Dehydrogenase. The invention was developed by Tao Fei, Tang Hongzhi, Li Chao ..

Sun Yat-sen University Submits Patent Application for Novel Methicillin-resistant Staphylococcus Aureus Phage and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Sun Yat-sen University has submitted a patent application for Novel Methicillin-resistant Staphylococcus Aureus Phage and Application Thereof. Wen Yao, Fu Yikai, Wang Mingfang, Deng Yinyue and Kong Xiaohan developed the invention. The patent application number is CN202610375953 20260325. The patent publica..

Shanghai Shali Biotechnology Co Ltd Submits Patent Application for Application of Gustation 2 Receptor Member 31 as Knockout Target in Cellular Immunotherapy

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shanghai Shali Biotechnology Co Ltd has submitted a patent application for Application of Gustation 2 Receptor Member 31 as Knockout Target in Cellular Immunotherapy. Liu Yarong, Sheng Yao and Sun Jingwei developed the invention. The patent application number is CN202610559552 20260427. The patent publicat..

State Intellectual Property Office of China Receives Shanghai Fengxian Central Hospital Patent Application for Drug-resistant Ewing Sarcoma Cell Line

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Shanghai Fengxian Central Hospital patent application for Drug-resistant Ewing Sarcoma Cell Line. Wang Yunyu, Kong Qian, Li Shiying and He Aina developed the invention. The patent application number is CN202610478148 20260413. The patent publication ..

Guangdong First Condor Biotechnology Co Ltd Submits Patent Application for Traditional Chinese Medicine Compound Cell Culture Fluid and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Guangdong First Condor Biotechnology Co Ltd has submitted a patent application for Traditional Chinese Medicine Compound Cell Culture Fluid and Application Thereof. Xie Haitao, He Juncheng and Xue Weiwei developed the invention. The patent application number is CN202610421798 20260401. The patent publicati..

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Applies for Patent on Anca-related Vasculitis Glomerular Endothelial Cell Injury Model, Construction Meth..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences has applied Chinese patent for Anca-related Vasculitis Glomerular Endothelial Cell Injury Model, Construction Method and Application Thereof, and Application of BACH1 Inhibitor. Chen Limeng, Xu Lubin, Zhang Shuo, Bai Linkun and Shi Xia..

Shanghai Jiao Tong University Submits Chinese Patent Application for Preparation Method and Application of Tomato Leaf Vacuole-free Cytoplasm

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shanghai Jiao Tong University has submitted a patent application for Preparation Method and Application of Tomato Leaf Vacuole-free Cytoplasm. This invention was developed by Chen Siyan, He Li, Huang Yanna and Tang Xueming. The patent application number is CN202610439687 20260403. The patent publication numb..

State Intellectual Property Office of China Publishes Shanghai Tongji Hospital Patent Application for Traditional Chinese Medicine Plant Rhizome-derived Cell Vesicles as Well as Pr..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Shanghai Tongji Hospital patent application for Traditional Chinese Medicine Plant Rhizome-derived Cell Vesicles as Well as Preparation Method and Application Thereof. The invention was developed by Shen Yuan, Zhu Lin, Nian Sunqi, Huang Lei, Kang Jiuho..

Nanchang University Applies for Patent on Application of Vesicles of Lactobacillus Mucosa in Preparation of Medicine for Treating Mafld

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Nanchang University has applied Chinese patent for Application of Vesicles of Lactobacillus Mucosa in Preparation of Medicine for Treating Mafld. Zhang Kaige, Wei Jing and Chen Tingtao developed it. The patent application number is CN202610517788 20260420. The patent publication number is CN122081176 (A). In..

Shandong New Time Pharmaceutical Products Submits Patent Application for Lactobacillus Plantarum LN-lp1 and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shandong New Time Pharmaceutical Products has submitted a patent application for Lactobacillus Plantarum LN-lp1 and Application Thereof. Zhao Jinwei, Teng Yongrong and Shi Wei developed the invention. The patent application number is CN202610430309 20260402. The patent publication number is CN122081168 (A)..

State Intellectual Property Office of China Receives Harbin Medical University Patent Application for Lactobacillus Helveticus Pp0208 and Application Thereof in Prevention and Trea..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Harbin Medical University patent application for Lactobacillus Helveticus Pp0208 and Application Thereof in Prevention and Treatment of Allergic Rhinitis. Li Xinhang, Fang Yong, Yuan Meng and Jiang Yichen developed the invention. The patent application..

Shenyang Pharmaceutical University Files Chinese Patent Application for Application of Probiotics and Vesicles Thereof in Preventing or Treating Inflammatory Bowel Disease

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shenyang Pharmaceutical University has filed a patent application for Application of Probiotics and Vesicles Thereof in Preventing or Treating Inflammatory Bowel Disease. This invention was developed by Zhao Peixu and Fu Qiang. The patent application number is CN202411682084 20241121. The patent publication ..

State Intellectual Property Office of China Receives Tsinghua University, East China University of Science and Technology and Shanghai Jiao Tong University Patent Application for E..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Tsinghua University, East China University of Science and Technology and Shanghai Jiao Tong University patent application for Engineered Pichia Pastoris and Application Thereof. Ruan Qingyun, Quan Shu, Zhang Chong and Liao Xihao developed the invention...

Changxing Pharmaceutical Co Ltd Submits Chinese Patent Application for Continuous Flow Enzyme Catalytic Reactor Coupled with Online Separation and Enzyme Membrane Recovery

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Changxing Pharmaceutical Co Ltd has submitted a patent application for Continuous Flow Enzyme Catalytic Reactor Coupled with Online Separation and Enzyme Membrane Recovery. This invention was developed by Zhang Likun, Ju Shuyun, Qian Minfan, Yu Haoran, Yang Weihua, Jiang Guangyu, Tang Dongying, Hua Chao and W..

State Intellectual Property Office of China Publishes Wuxi Shengji Pharmaceutical Tech Co Ltd Patent Application for Tangential Flow System Capable of Controlling Concentration End..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Wuxi Shengji Pharmaceutical Tech Co Ltd patent application for Tangential Flow System Capable of Controlling Concentration End Point and Liquid Exchange End Point and Operation Method of Tangential Flow System. The invention was developed by He Ronghua..

Zhejiang Haizhixin Pharmaceutical Co Ltd Submits Chinese Patent Application for Heavy-phase Distillation Retort for Separating Fish Oil

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Zhejiang Haizhixin Pharmaceutical Co Ltd has submitted a patent application for Heavy-phase Distillation Retort for Separating Fish Oil. This invention was developed by Ying Jintao, Ying Wenjun, Zhao Yadong and Ying Hongjie. The patent application number is CN202610299990 20260312. The patent publication n..

State Intellectual Property Office of China Publishes Zhejiang Haizhixin Pharmaceutical Co Ltd Patent Application for Anti-wall-sticking High-efficiency Decolorizing Kettle for Ref..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Zhejiang Haizhixin Pharmaceutical Co Ltd patent application for Anti-wall-sticking High-efficiency Decolorizing Kettle for Refining Fish Oil. The invention was developed by Ying Jintao, Ying Wenjun, Zhao Yongjun, Zhao Yadong and Ying Hongjie. The pa..

Suzhou Boyang Chemical Seeks Patent for BOE Etching Solution and Preparation Method Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Suzhou Boyang Chemical has sought patent for BOE Etching Solution and Preparation Method Thereof. This invention was developed by Wang Runjie, Yan Xili and Chen Bin. The patent application number is CN202610559576 20260427. The patent publication number is CN122080937 (A). International Patent Classificati..

Sichuan University Submits Chinese Patent Application for Method for Enhancing Uranyl Ion Intrinsic Luminescence Through Macrocyclic Ligand and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Sichuan University has submitted a patent application for Method for Enhancing Uranyl Ion Intrinsic Luminescence Through Macrocyclic Ligand and Application Thereof. This invention was developed by Wu Lan, Pu Shan and Miao Mengxi. The patent application number is CN202610210545 20260213. The patent publicatio..

Southwest Petroleum University Submits Patent Application for Mannich Base Quaternary Ammonium Salt Corrosion Inhibitor for Acidification of Ultra-high-temperature Well and Prepara..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Southwest Petroleum University has submitted a patent application for Mannich Base Quaternary Ammonium Salt Corrosion Inhibitor for Acidification of Ultra-high-temperature Well and Preparation Method Thereof. Zhang Yang, Yu Jia, Xia Dingfeng, Zhang Shiling, Wang Qihai, Qiao Yan, Luo Zhifeng, Shang Litao, He Z..

Jiangsu Lianshui Pharmaceutical Co Ltd Submits Chinese Patent Application for Purification Treatment Equipment for Purified Water

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Jiangsu Lianshui Pharmaceutical Co Ltd has submitted a patent application for Purification Treatment Equipment for Purified Water. This invention was developed by He Hong, Zhu Jun and Schling. The patent application number is CN202610256424 20260304. The patent publication number is CN122079389 (A). Intern..

Shaanxi Didu Pharmaceutical Chemical Co Ltd Applies for Patent on Green Synthesis Process and Purification Method of High-purity Lithium Hexafluoroarsenate

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shaanxi Didu Pharmaceutical Chemical Co Ltd has applied Chinese patent for Green Synthesis Process and Purification Method of High-purity Lithium Hexafluoroarsenate. Chen Jing, Liu Ruigang, Zhang Dong, Gao Shaohui and Feng Jili developed it. The patent application number is CN202610446731 20260407. The pat..

University of Macau Seeks Patent for Carbon Dot, Preparation Method and Application Thereof, and Antitumor Drug

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- University of Macau has sought patent for Carbon Dot, Preparation Method and Application Thereof, and Antitumor Drug. This invention was developed by Qu Songnan and Li Lingyun. The patent application number is CN202610215344 20260214. The patent publication number is CN122079136 (A). International Patent Cla..

State Intellectual Property Office of China Receives Meilan Hangzhou Pharmaceutical Tech Patent Application for Medicine Bottle Position Deviation Rectifying Method and System

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Meilan Hangzhou Pharmaceutical Tech patent application for Medicine Bottle Position Deviation Rectifying Method and System. Tan Lili, Fu Xiaoyang and Liao Wen developed the invention. The patent application number is CN202610220871 20260224. The patent..

Henan Houyi Bioengineering Co Ltd Applies for Patent on Porcine Circovirus Vaccine Filling Equipment

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Henan Houyi Bioengineering Co Ltd has applied Chinese patent for Porcine Circovirus Vaccine Filling Equipment. Wu Hongyun, Liu Yingpeng, Ding Xianhong, Xu Jin, Guo Xiaoqing, Luo Aifang and Fan Huili developed it. The patent application number is CN202610232058 20260227. The patent publication number is CN1..

State Intellectual Property Office of China Releases Beijing Zhongke Gene Tech Co Ltd and Luoyang Putai Biotechnology Co Ltd Patent Application for Truncated Fragment of African Sw..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Beijing Zhongke Gene Tech Co Ltd and Luoyang Putai Biotechnology Co Ltd patent application for Truncated Fragment of African Swine Fever Virus C129r Protein and Antibody or Antigen Binding Fragment Thereof and Application. This invention was developed b..

State Intellectual Property Office of China Releases Beijing Zhongke Gene Tech Co Ltd and Luoyang Putai Biotechnology Co Ltd Patent Application for Truncated Fragment of African Sw..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Beijing Zhongke Gene Tech Co Ltd and Luoyang Putai Biotechnology Co Ltd patent application for Truncated Fragment of African Swine Fever Virus Pb602l Protein and Antibody or Antigen Binding Fragment and Application Thereof. This invention was developed ..

State Intellectual Property Office of China Receives Peking University People's Hospital and Beijing Shouyi Zhijian Medical Tech Co Ltd Patent Application for Application of Antige..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Peking University People's Hospital and Beijing Shouyi Zhijian Medical Tech Co Ltd patent application for Application of Antigen Peptide Eg16 and Antibody Thereof in Preparation of Rheumatoid Arthritis Diagnostic Product. Cai Xuanlin, Hu Fanlei, Cao Lul..

China Pharmaceutical University Submits Chinese Patent Application for Earthworm Anticoagulant Oligopeptide and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- China Pharmaceutical University has submitted a patent application for Earthworm Anticoagulant Oligopeptide and Application Thereof. This invention was developed by Xie Xinrong, Yu Boyang and Liu Xiufeng. The patent application number is CN202610331113 20260318. The patent publication number is CN122080132 (..

China Pharmaceutical University Files Chinese Patent Application for Estradiol Anti-depression Derivative as Well as Preparation Method and Medical Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- China Pharmaceutical University has filed a patent application for Estradiol Anti-depression Derivative as Well as Preparation Method and Medical Application Thereof. This invention was developed by Gao Chunyu, Sun Jianbo and Wang Jianxin. The patent application number is CN202511829655 20251205. The patent ..

State Intellectual Property Office of China Releases Yunnan Zewei Pharmaceutical Co Ltd Patent Application for Method for Decolorizing Steroid Intermediate Dihydroxy Compound

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Yunnan Zewei Pharmaceutical Co Ltd patent application for Method for Decolorizing Steroid Intermediate Dihydroxy Compound. This invention was developed by Jiang Kefeng, Tan Zhaoe, Zhang Qian and Wang Qiangang. The patent application number is CN20251..

Zhaoke Pharmaceutical Hefei Co Ltd Submits Chinese Patent Application for Preparation Method of Androstane-3, 6, 17-trione (e, Z)-3-[o-(2-aminoethyl)] Oxime Hydrochloride

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Zhaoke Pharmaceutical Hefei Co Ltd has submitted a patent application for Preparation Method of Androstane-3, 6, 17-trione (e, Z)-3-[o-(2-aminoethyl)] Oxime Hydrochloride. This invention was developed by Huang Sijia, Hu Changliang, Chen Jingsong, Li Gang and Li Xiaoyi. The patent application number is CN20..

State Intellectual Property Office of China Receives Hubei Wudang Antai Pharmaceutical Co Ltd Patent Application for Preparation Method of Dehydroepiandrosterone

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Hubei Wudang Antai Pharmaceutical Co Ltd patent application for Preparation Method of Dehydroepiandrosterone. Chen Chunsun and Wen Wen developed the invention. The patent application number is CN202610297499 20260312. The patent publication number is..

Yunnan Zewei Pharmaceutical Co Ltd Applies for Patent on Synthesis Process of Estetrol

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Yunnan Zewei Pharmaceutical Co Ltd has applied Chinese patent for Synthesis Process of Estetrol. Jiang Kefeng, Tan Zhaoe, Zhang Qian and Wang Qiangang developed it. The patent application number is CN20251207536 20251229. The patent publication number is CN122080101 (A). International Patent Classification..

Tianjin University Seeks Patent for Cobalamin Derivative, Preparation Method Thereof and Application of Cobalamin Derivative in Synthesis of Arsenotricin

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Tianjin University has sought patent for Cobalamin Derivative, Preparation Method Thereof and Application of Cobalamin Derivative in Synthesis of Arsenotricin. This invention was developed by Dong Min, Chen Fan and Wang Haoxin. The patent application number is CN202610542202 20260423. The patent publication ..

State Intellectual Property Office of China Receives Tianjin University Patent Application for S-adenosine Homocysteine Analogue, S-adenosine-l-methionine Analogue and Application ..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Tianjin University patent application for S-adenosine Homocysteine Analogue, S-adenosine-l-methionine Analogue and Application of S-adenosine Homocysteine Analogue and S-adenosine-l-methionine Analogue. Dong Min and Chen Fan developed the invention. Th..

Guangxi University of Chinese Medicine Submits Patent Application for Fucosylated Heparin Pentasaccharide as Well as Preparation Method and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Guangxi University of Chinese Medicine has submitted a patent application for Fucosylated Heparin Pentasaccharide as Well as Preparation Method and Application Thereof. Jiang Peiqi, Zhao Longyan, Yuan Qingxia, Fu Jiewen, Nongjiale, Lyu Xusheng, Shi Xiang, Zhao Yuemou and Huang Jinying developed the invention...

Chengdu Yazhong Bio Pharmaceutical Co Ltd Submits Chinese Patent Application for Preparation Method and Application of Diosmin Impurity Compound

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Chengdu Yazhong Bio Pharmaceutical Co Ltd has submitted a patent application for Preparation Method and Application of Diosmin Impurity Compound. This invention was developed by Wen Wandong and Xiao Guoqing. The patent application number is CN202610312636 20260316. The patent publication number is CN122080..

State Intellectual Property Office of China Publishes Tianjin Institute Pharmaceutical Co Ltd Patent Application for Tannin Derivative as Well as Preparation Method and Application..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Tianjin Institute Pharmaceutical Co Ltd patent application for Tannin Derivative as Well as Preparation Method and Application Thereof. The invention was developed by Wang Xiaoliang, Meng Caiwen, Zhao Chunlai, Li Meichen, He Yi, Wang Ruyi, Wang Zijia a..

State Intellectual Property Office of China Publishes Beijing Institute of Petrochemical Technology Patent Application for Method for Ultrasonic Extraction of Flavonol Glycosides i..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Beijing Institute of Petrochemical Technology patent application for Method for Ultrasonic Extraction of Flavonol Glycosides in Herba Epimedii with Assistance of Eutectic Solvent. The invention was developed by Yang Simin, Zhang Jieru, Ju Ruijun, Peng ..

State Intellectual Property Office of China Receives Soochow University Patent Application for Metal-based Photosensitizer, Pharmaceutical Composition and Application

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Soochow University patent application for Metal-based Photosensitizer, Pharmaceutical Composition and Application. Jiao Ying, Li Shengliang, Qian Xiandie, Cen Cui, Zhao Qi, Wang Yu and Yu Jie developed the invention. The patent application number is CN..

Guoke Wenzhou Research Institute Wenzhou Institute Of Biomaterials And Engineering Seeks Patent for Aryl Boron Compound, Preparation Method and Application Thereof, and Pharmaceuti..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Guoke Wenzhou Research Institute Wenzhou Institute Of Biomaterials And Engineering has sought patent for Aryl Boron Compound, Preparation Method and Application Thereof, and Pharmaceutical Composition. This invention was developed by Wang Wentao, Han Jung, Yang Guoqiang and Ju Jian. The patent application ..

Hubei Hongyuan Pharmaceutical Tech Co Ltd Applies for Patent on Method and Device for Continuously Preparing Lithium Difluoro (oxalato) Borate

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Hubei Hongyuan Pharmaceutical Tech Co Ltd has applied Chinese patent for Method and Device for Continuously Preparing Lithium Difluoro (oxalato) Borate. Jia Xuefeng, Peng Pengcheng, Li Rui, Jin Qiao, Xiao Peng, Shu Weifeng and Hu Jian developed it. The patent application number is CN202610259993 20260304. ..

State Intellectual Property Office of China Publishes Tianjin University Patent Application for Dysprosium-based Magnetoelectric Compound with Magnetic Control Electric Behavior an..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Tianjin University patent application for Dysprosium-based Magnetoelectric Compound with Magnetic Control Electric Behavior and Preparation Method and Application of Dysprosium-based Magnetoelectric Compound. The invention was developed by Wang Yuxia, ..

CSPC Zhongnuo Pharmaceutical Shijiazhuang Co Ltd Files Chinese Patent Application for Method and Device for Continuously Crystallizing Cefixime

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- CSPC Zhongnuo Pharmaceutical Shijiazhuang Co Ltd has filed a patent application for Method and Device for Continuously Crystallizing Cefixime. This invention was developed by Liu Yaozong, Li Shicheng, Ma Wenchan, Chen Yingxin and Huang Xuechuan. The patent application number is CN202610211727 20260213. The..

State Intellectual Property Office of China Releases Suzhou Gongkang Medicine Tech Co Ltd Patent Application for Carbamate Krasg12d Mutant Inhibitor

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Suzhou Gongkang Medicine Tech Co Ltd patent application for Carbamate Krasg12d Mutant Inhibitor. This invention was developed by Chen Yang, Kai Shaoxing and Chen Shuai. The patent application number is CN202510839748 20250623. The patent publication ..

Hebei Xingang Pharmaceutical Co Ltd Submits Chinese Patent Application for Synthesis Process for Preparing Rifampicin by Taking Rifamycin O as Starting Material

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Hebei Xingang Pharmaceutical Co Ltd has submitted a patent application for Synthesis Process for Preparing Rifampicin by Taking Rifamycin O as Starting Material. This invention was developed by Zhao Jianqiang, Zhang Wanzhi, Shi Shoukun, Quan Yanqing and Li Kejing. The patent application number is CN2026102..

Taizhou University Files Chinese Patent Application for Indole Compound as Well as Preparation Method and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Taizhou University has filed a patent application for Indole Compound as Well as Preparation Method and Application Thereof. This invention was developed by Mui, Ji Jiali, Wang Yao, Niu Minjia, Ji Jing and Lee Kyeong. The patent application number is CN202610107750 20260122. The patent publication number i..

Institute of Materia Medica, Chinese Academy of Medical Sciences Submits Patent Application for Thienopyrimidine Derivative as Well as Preparation Method, Application and Pharmaceu..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Institute of Materia Medica, Chinese Academy of Medical Sciences has submitted a patent application for Thienopyrimidine Derivative as Well as Preparation Method, Application and Pharmaceutical Composition Thereof. Zhou Wen, Wu Deyu, Jin Jing, Tian Hua, Lin Songwen, Gong Hang, Xu Heng, Liu Wenqian, Zhang Kehu..

Nantong University Files Chinese Patent Application for Flavanone Indole Derivative as Well as Preparation Method and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Nantong University has filed a patent application for Flavanone Indole Derivative as Well as Preparation Method and Application Thereof. This invention was developed by Han Jianxing, Zhao Yu, Ma Yujie, Lu Qinyao, Ji Siwei and Yang Fan. The patent application number is CN202610258847 20260304. The patent pu..

State Intellectual Property Office of China Releases Southern Medical University and Henan University of Chinese Medicine Patent Application for Pd-1/pd-l1 and Jak Double-target In..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Southern Medical University and Henan University of Chinese Medicine patent application for Pd-1/pd-l1 and Jak Double-target Inhibitor as Well as Preparation Method and Application Thereof. This invention was developed by Tan Jun, Chen Jianjun, He Haiqi..

State Intellectual Property Office of China Publishes Tlc Nanjing Pharmaceutical Res And Development Co Ltd Patent Application for Preparation Method of Abacavir Metabolite

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Tlc Nanjing Pharmaceutical Res And Development Co Ltd patent application for Preparation Method of Abacavir Metabolite. The invention was developed by He Xu, Yang Shi, Zhang Chi and He Wenjing. The patent application number is CN202610197587 2026021..

Jiaying University Applies for Patent on Purine [1, 2-a] Carbazoline Derivative as Well as Preparation Method and Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Jiaying University has applied Chinese patent for Purine [1, 2-a] Carbazoline Derivative as Well as Preparation Method and Application Thereof. Xie Yuman, Zeng Huang, Huang Hui, Yang Junlong, Zhang Shengyuan and Nie Hua developed it. The patent application number is CN202610260534 20260304. The patent publ..

Eli Lilly and Company Files Chinese Patent Application for Fgfr3 Inhibitor Compounds

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Eli Lilly and Company has filed a patent application for Fgfr3 Inhibitor Compounds. This invention was developed by A D Abraham, Dilger Andrew K, Hazlitt Richard A, Kercher Timothy S, Boomer Dennis D, Metcalf Andrew T, Walls Shane M, Condroski Kevin Ronald and Urkaran Kiran B. The patent application number i..

State Intellectual Property Office of China Releases Zhejiang Saimo Pharmaceutical Co Ltd and Hanghzou Bio Sincerity Pharma Tech Cop Ltd Patent Application for Crystal Form of Fene..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Zhejiang Saimo Pharmaceutical Co Ltd and Hanghzou Bio Sincerity Pharma Tech Cop Ltd patent application for Crystal Form of Fenerenone Optically Active Intermediate Iia and Preparation Method Thereof. This invention was developed by Liu Baoqing, Li Cheng..

State Intellectual Property Office of China Receives Haisco Pharmaceutical Group Inc Patent Application for Benzofuran Derivative and Medical Application Thereof

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Haisco Pharmaceutical Group Inc patent application for Benzofuran Derivative and Medical Application Thereof. Li Yao, He Ping, Qin Lin, Wang Le, Ning Wentao, Yan Pangke, Liao Pengfei and Zhang Chen developed the invention. The patent application numb..

State Intellectual Property Office of China Publishes Changzhou Yabang Qh Pharmachem Co Ltd and Inner Mongolia Qihui Pharmaceutical Co Ltd Patent Application for Preparation Method..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Changzhou Yabang Qh Pharmachem Co Ltd and Inner Mongolia Qihui Pharmaceutical Co Ltd patent application for Preparation Method of Degraded Impurities of Lentirapane. The invention was developed by Xie Xin, Meng Xiangyan, Wang Xuecheng, Jin Yefeng and Z..

Alpha Pharmaceutical Co Ltd Jiangsu Province Submits Patent Application for Process for Catalytic Synthesis of Acetyl Empagliflozin and Active Carrier Catalyst

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Alpha Pharmaceutical Co Ltd Jiangsu Province has submitted a patent application for Process for Catalytic Synthesis of Acetyl Empagliflozin and Active Carrier Catalyst. Zhang Yahui, Zhang Shengquan, Cao Meng, Jian Yong and Wang Ziqi developed the invention. The patent application number is CN202610126891 2..

University Liaoning Traditional Chinese Medicine Submits Patent Application for Extraction and Separation Method and Application of Indole Alkaloids

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- University Liaoning Traditional Chinese Medicine has submitted a patent application for Extraction and Separation Method and Application of Indole Alkaloids. Liu Jing, Liu Pengyan, Gao Xiyue, Zhang Zhiwei and Ying Zheming developed the invention. The patent application number is CN202610466609 20260410. Th..

Alpha Pharmaceutical Co Ltd Jiangsu Province Submits Patent Application for Synthesis Process of (4r-cis)-6-formyl-2, 2-dimethyl-1, 3-dioxane-4-tert-butyl Acetate

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Alpha Pharmaceutical Co Ltd Jiangsu Province has submitted a patent application for Synthesis Process of (4r-cis)-6-formyl-2, 2-dimethyl-1, 3-dioxane-4-tert-butyl Acetate. Wen Shuang, Yuan Haibo, Zhou Hui, Cao Meng and Jian Yong developed the invention. The patent application number is CN202610383126 20260..

University Liaoning Traditional Chinese Medicine Seeks Patent for Novel Triterpenoid in Acanthopanax Sessiliflorus, Epimer of Triterpenoid and Extraction and Separation Method and ..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- University Liaoning Traditional Chinese Medicine has sought patent for Novel Triterpenoid in Acanthopanax Sessiliflorus, Epimer of Triterpenoid and Extraction and Separation Method and Application of Triterpenoid. This invention was developed by Feng Libao, Han Xueying, Ran Xiaoku, Dou Deqiang and Liu Linlin...

Fu Xuwei Submits Patent Application for Synthesis Method of 6-bromine-5-amino-3, 4-dihydro-2h-1-benzopyran-8-formic Acid and Derivative of 6-bromine-5-amino-3, 4-dihydro-2h-1-benzo..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Fu Xuwei has submitted a patent application for Synthesis Method of 6-bromine-5-amino-3, 4-dihydro-2h-1-benzopyran-8-formic Acid and Derivative of 6-bromine-5-amino-3, 4-dihydro-2h-1-benzopyran-8-formic Acid. Zhang Mengmeng, Zhao Shuhui, He Pan, Wang Zhuang and Huang Yanhua developed the invention. The pat..

Hebei Hejia Pharmatech Group Co Ltd Submits Chinese Patent Application for Preparation Method of Cefixime Side Chain Acid Active Ester with Stable Quality

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Hebei Hejia Pharmatech Group Co Ltd has submitted a patent application for Preparation Method of Cefixime Side Chain Acid Active Ester with Stable Quality. This invention was developed by Ren Feng, Kim Seok, Li Yang, Jiang Pengpeng, Qi Peng, Xia Tong, Tian Hongnian, Zheng Xiaoxia, Sun Shoujie, Pi Chunhan and ..

State Intellectual Property Office of China Receives Tianjin University Patent Application for Raspberry Ketone Compound, Synthesis Thereof and Application of Raspberry Ketone Comp..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Tianjin University patent application for Raspberry Ketone Compound, Synthesis Thereof and Application of Raspberry Ketone Compound in Prevention and Treatment of Plant Viruses, Germs and Diseases. Wang Ziwen and Zhao Zhiting developed the invention. T..

State Intellectual Property Office of China Publishes Suzhou Vocational Health College Patent Application for Isoxazole Biphenyl Compounds with CBP BRD and BRD4 BD2 Inhibitory Acti..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has published Suzhou Vocational Health College patent application for Isoxazole Biphenyl Compounds with CBP BRD and BRD4 BD2 Inhibitory Activity as Well as Preparation Method and Application of Isoxazole Biphenyl Compounds. The invention was developed by Zhang Maofe..

Anhui Menovo Pharmaceuticals Co Ltd Files Chinese Patent Application for Valsartan Disodium Intermediate

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Anhui Menovo Pharmaceuticals Co Ltd has filed a patent application for Valsartan Disodium Intermediate. This invention was developed by Xu Kun, Yin Liangjun, Sun Haitao and Yang Ji. The patent application number is CN202610230693 20260227. The patent publication number is CN122079916 (A). International Pat..

State Intellectual Property Office of China Receives Yantai Lannacheng Biotechnology Patent Application for Al18F-labeled PSMA Radiopharmaceutical as Well as Preparation Method and..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Yantai Lannacheng Biotechnology patent application for Al18F-labeled PSMA Radiopharmaceutical as Well as Preparation Method and Application of Al18F-labeled PSMA Radiopharmaceutical. Ma Weiwei, Li Yajing, Wen Xuejun, Wu Xiaoming and He Tian developed th..

State Intellectual Property Office of China Releases Jiangsu Yutian Pharmaceutical Co Ltd Patent Application for Synthesis Method of Lesinurad

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Jiangsu Yutian Pharmaceutical Co Ltd patent application for Synthesis Method of Lesinurad. This invention was developed by Zhu Wanli, Yan Xuefeng, Yu Jun, Meng Yunlong, Zhu Liangliang and Lu Qiangqiang. The patent application number is CN202511985336..

Henan University of Medicine Applies for Patent on Synthetic Method of Quinoxaline-2 (1H)-ketone Derivative Containing Sf5 Group

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Henan University of Medicine has applied Chinese patent for Synthetic Method of Quinoxaline-2 (1H)-ketone Derivative Containing Sf5 Group. Sun Bo, Wang Huiping, Tan Xinqiang, Deng Yunjing, Wang Yingling and Hao Ziyou developed it. The patent application number is CN202610122428 20260129. The patent publica..

State Intellectual Property Office of China Releases Shaanxi University of Chinese Medicine Patent Application for Preparation Method of N-aryl Pyrazole Compound

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Shaanxi University of Chinese Medicine patent application for Preparation Method of N-aryl Pyrazole Compound. This invention was developed by Ding Zhiwei, Guo Hui, Zhang Xin, Zhou Jing, Wu Tongyue, Sun Zhuoran, Zhang Dongdong, Yan Hao, Song Xiao, Zhao P..

State Intellectual Property Office of China Releases Zhejiang Soin Pharmaceutical Co Ltd and Zhejiang Yongtai Technology Co Ltd Patent Application for Preparation Method of Remegap..

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has released Zhejiang Soin Pharmaceutical Co Ltd and Zhejiang Yongtai Technology Co Ltd patent application for Preparation Method of Remegapam Intermediate. This invention was developed by Tu Jiaqiu, Weng Jianfeng, Huang Tianbao, Bai Congcong, Xia Haijian and Chen H..

Anhui Menovo Pharmaceuticals Co Ltd Submits Chinese Patent Application for Marbofloxacin Intermediate

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Anhui Menovo Pharmaceuticals Co Ltd has submitted a patent application for Marbofloxacin Intermediate. This invention was developed by Yang Chengchao, Sun Haitao, Wang Bangfeng and Yang Ji. The patent application number is CN202610214395 20260214. The patent publication number is CN122079888 (A). Internati..

State Intellectual Property Office of China Receives Wuxi Jida Pharmaceutical Co Ltd Patent Application for Method for Purifying Etoricoxib Impurities

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- State Intellectual Property Office of China has received Wuxi Jida Pharmaceutical Co Ltd patent application for Method for Purifying Etoricoxib Impurities. Zhang Qingli, Zou Xiaobin, Lu Changjian, Zhou Muyuan, Feng Yanguang and Yang Xin developed the invention. The patent application number is CN2026104427..

Shenyang Pharmaceutical University Submits Patent Application for Synthesis Method of N-alkoxycarbonyl-4-amino-4-alkyl Piperidine

Pharmaceutical

| Wed 12 Aug 2026

Beijing, Aug. 12 -- Shenyang Pharmaceutical University has submitted a patent application for Synthesis Method of N-alkoxycarbonyl-4-amino-4-alkyl Piperidine. Zhang Xinxing, Fu Xinyi and Peng Wei developed the invention. The patent application number is CN202610537000 20260422. The patent publication number is CN122079868 (A). ..

1 to 100 of 1344 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles